Vendor-neutral device import consistently outperforms manual transcription in pulmonary function laboratories, reducing data entry time, eliminating transcription errors, and freeing respiratory scientists to focus on clinical interpretation rather than administrative tasks. In multi-brand lab environments where spirometers, diffusion systems, and body plethysmographs from different manufacturers coexist, the operational cost of manual data entry compounds daily. Platforms like Rezibase address this directly through automated import tools designed specifically for the realities of clinical physiology workflows.

TL;DR

• Manual transcription in multi-brand labs creates compounding inefficiencies and measurable clinical risk from transcription errors.

• Vendor-neutral import tools can significantly reduce per-patient data entry time across device brands.

• Standards like FHIR, DICOM, and HL7 underpin interoperability but require purpose-built implementation to deliver real-world value.

• Switching from a legacy system to a vendor-neutral platform is more straightforward than most labs expect.

• The right platform is built by people who understand the lab, not just the software.

About the Author: This article is written by the Rezibase team, a group of respiratory scientists and healthcare technology specialists with over 37 years of combined experience building and deploying respiratory and sleep reporting solutions across Australian and UK clinical physiology laboratories.

Why Does Data Entry Method Matter So Much in Pulmonary Function Labs?

Manual transcription is not just slow. It is a structural risk embedded into every patient encounter. In a pulmonary function laboratory, a single test session can generate dozens of discrete data points: FEV1, FVC, TLC, DLCO, flow-volume loop coordinates, and more. When a scientist must re-enter these values by hand from a device printout into a reporting system, every keystroke is an opportunity for error.

The problem scales with lab complexity. A multi-brand environment, where a Vyaire spirometer sits alongside a CareFusion body box and a Jaeger diffusion system, means no single proprietary export format works across all devices. Scientists are often left bridging the gap manually.

Key consequences of manual transcription in this context include:

• Increased time per patient: Each manual entry adds minutes that accumulate into hours across a full clinic day.

• Transcription errors: Transposed digits, missed values, and unit mismatches introduce clinical risk that is difficult to audit retrospectively.

• Scientist fatigue: Repetitive data entry is cognitively draining and diverts attention from the interpretive work that requires clinical expertise.

• Audit trail gaps: Manual processes are harder to standardise and document for accreditation purposes.

What Do Real-World Time Studies Show About Manual vs. Automated Import?

Time-motion studies in clinical settings consistently show that manual data entry is one of the largest non-clinical time burdens on healthcare professionals. While pulmonary function lab-specific published benchmarks remain limited in peer-reviewed literature, the broader pattern from clinical data management research is instructive.

Work published in the Journal of Imaging Informatics in Medicine through a HIMSS-SIIM collaborative white paper highlighted that vendor-neutral orchestration between data capture and reporting tools remains an unresolved challenge across many specialties, with further standardisation work needed to reduce friction at the point of data handoff. This finding reflects precisely what multi-brand pulmonary function labs experience daily.

In practical terms, the difference between manual and automated import breaks down as follows:

These differences are not trivial. Across a lab running 20 patients per day, even a conservative five-minute saving per patient represents over 1.5 hours of recovered scientist time daily.

How Does Vendor-Neutral Integration Actually Work in a Multi-Brand Lab?

Vendor-neutral integration relies on open data standards that allow different devices and systems to communicate without requiring proprietary middleware from each manufacturer. The core standards enabling this are FHIR (Fast Healthcare Interoperability Resources), DICOM, and HL7, which together define how clinical data is structured, transmitted, and received across systems.

As noted by AGFA HealthCare in their enterprise imaging platform documentation, open standards-based APIs using FHIR, DICOM, HL7, and IHE profiles enable vendor-neutral integration across EHRs, reporting tools, scheduling systems, and advanced imaging applications. The same principle applies directly to pulmonary function data: when a reporting platform is built on these standards, it can receive data from any compliant device regardless of manufacturer.

For a lab with mixed device brands, this means:

• Device output is parsed and mapped to standardised data fields automatically.

• Discrete values are extracted, not just images or PDFs.

• Flow-volume loops and raw waveform data can be captured alongside numerical results.

• The reporting system receives structured data ready for clinical interpretation.

Rezibase's Magic Import function applies this principle in practice, allowing labs to import device reports directly and extract discrete data including flow-volume loops, without manual re-entry and without being tied to any single device manufacturer.

What Are the Localization and Compliance Considerations for Multi-Site Labs?

For labs operating across multiple sites or jurisdictions, data entry standardisation intersects with regulatory and localization requirements. Device documentation, user interfaces, and data outputs may vary by region, and the reporting system must accommodate these differences without introducing inconsistency.

Guidance from Linguistic Systems on medical device translation best practices notes that high-quality translation of user interfaces and instructions is essential for highly regulated, life-saving medical environments. When device outputs arrive in different formats or languages across sites, an automated import layer that normalises this variation before data reaches the reporting system reduces both compliance risk and operational complexity.

For multi-national deployments, such as labs operating across Australia and the UK, this standardisation layer is not optional. It is what makes consistent reporting possible.

Is Switching From a Legacy System to a Vendor-Neutral Platform Complicated?

Switching platforms is often perceived as disruptive, but the practical reality for most labs is more manageable than expected. The key factors that determine transition complexity are data migration scope, integration requirements, and staff training, all of which are addressable with the right implementation approach.

For labs moving to Rezibase from a previous system such as Respiro, the transition is designed to be straightforward. Historical patient data can be migrated, existing device connections are maintained through vendor-neutral import, and the cloud-based delivery model means there is no local server infrastructure to reconfigure.

Practical steps that simplify the transition:

1. Audit existing data: Identify what needs to be migrated and in what format.

2. Map device outputs: Confirm which devices are in use and validate import compatibility.

3. Configure normal values: Use a pre-loaded library rather than rebuilding from scratch.

4. Train staff in context: Focus training on workflow improvements, not just software navigation.

5. Run in parallel briefly: Overlap old and new systems for a short period to validate data integrity.

The goal is continuity of care, not disruption of it.

Frequently Asked Questions

Can vendor-neutral import handle all pulmonary function device brands?
A well-implemented vendor-neutral platform can handle output from any device that produces a structured or semi-structured report. Rezibase's Magic Import is designed to work across device manufacturers without requiring proprietary connectors.

Does automated import capture flow-volume loops, or just numerical values?
Rezibase's Magic Import extracts discrete data including flow-volume loops, not just summary numbers. This is a meaningful clinical distinction.

How does automated import affect accreditation compliance?
Automated import creates consistent, timestamped audit trails that support accreditation requirements. Rezibase includes a dedicated accreditation module aligned with TSANZ/NATA Standards and ISO 15189 requirements.

What happens to historical data when switching platforms?
Historical data can be migrated as part of the transition process. The approach is to move what is clinically relevant without requiring labs to rebuild records from scratch.

Is a cloud-based system secure enough for clinical data?
Cloud-based clinical systems are subject to the same security and compliance standards as on-premise solutions. Rezibase is also available for on-premise enterprise deployment for hospitals with specific infrastructure requirements.

How long does implementation typically take?
Implementation timelines vary by site complexity, but the cloud-based model removes the longest delays associated with traditional server-based deployments.

Does Rezibase support integration with hospital systems beyond device import?
Yes. Rezibase integrates with Patient Administration Systems, EMR systems, DICOM Modality Worklists, Hospital Finance Systems, and Electronic Orders Systems.

About Rezibase

Rezibase is Australia's most advanced cloud-based respiratory and sleep reporting platform, built by respiratory scientists for respiratory scientists. Trusted by over 35 sites including NHS hospitals in the UK and NSW Health in Australia, Rezibase delivers vendor-neutral device import, AI-assisted reporting, accreditation management, and full administrative workflow support under a transparent, no lock-in monthly pricing model. Backed by 37 years of respiratory science expertise and the technology capabilities of parent company Cardiobase, Rezibase exists to reduce clinical risk, eliminate double data entry, and give scientists more time for the work that matters.

Learn more or start your 30-day free trial at rezibase.com.

References

• AGFA HealthCare. Enterprise Imaging Platform. https://www.agfahealthcare.com/enterprise-imaging-platform/

• Berkowitz, S.J. et al. Interactive Multimedia Reporting Technical Considerations: HIMSS-SIIM Collaborative White Paper. https://link.springer.com/article/10.1007/s10278-022-00658-z

• Linguistic Systems. Medical Device Translation Best Practices. https://linguist.com/2023/05/medical-device-translation-best-practices/